Page 343 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 24 Complement and Immunoglobulin Biology Leading to Clinical Translation 284.e1

REFERENCES 22. Kolb WP, Morrow PR, Tamerius JD: Ba and Bb fragments of factor
B activation: Fragment production, biological activities, neoepitope
1. Silverstein AM: A history of immunology, ed 2, San Diego, CA, 1989, expression and quantitation in clinical samples. Complement Inflamm
Academic Press, p 552. 6:175, 1989.
2. Volanakis JE, Frank MM, editors: The human complement system in 23. Janssen BJ, Huizinga EG, Raaijmakers HC, et al: Structures of comple-
health and disease, ed 2, New York, 1998, Marcel Dekker. ment component C3 provide insights into the function and evolution
3. Whaley K, Weiler JM, Loos M, editors: Complement in health and of immunity. Nature 437:505, 2005.
disease, London, 1993, Kluwer Academic Publishers, p 352. 24. Janssen BJ, Christodoulidou A, McCarthy A, et al: Structure of C3b
4. Zhang P, Summer WR, Bagby GJ, et al: Innate immunity and pulmo- reveals conformational changes that underlie complement activity.
nary host defense. Immunol Rev 173:39, 2000. Nature 444:213, 2006.
5. Aderem A, Underhill DM: Mechanisms of phagocytosis in macro- 25. Wiesmann C, Katschke KJ, Yin J, et al: Structure of C3b in complex
phages. Annu Rev Immunol 17:593, 1999. with CRIg gives insights into regulation of complement activation.
6. Hartmann K, Henz BM, Krüger-Krasagakes S, et al: C3a and C5a Nature 444:217, 2006.
stimulate chemotaxis of human mast cells. Blood 89:2863, 1997. 26. Takahashi M, Ishida Y, Iwaki D, et al: Essential role of mannose-binding
7. Höpken UE, Lu B, Gerard NP, et al: The C5a chemoattractant receptor lectin-associated serine protease-1 in activation of the complement
mediates mucosal defense to infection. Nature 383:86, 1996. factor D. J Exp Med 207:29, 2010.
8. Cooper NR: The classical complement pathway: Activation and 27. Nishida N, Walz T, Springer TA: Structural transitions of complement
regulation of the first complement component. Adv Immunol 37:151, component C3 and its activation products. Proc Natl Acad Sci USA
1985. 103:19737, 2006.
9. Loos M, Petry F, Colomb M, et al: Complement component C1 and 28. Brodbeck WG, Mold C, Atkinson JP, et al: Cooperation between
the collectins: Preface. Immunobiology 199:I, 1998. decay-accelerating factor and membrane cofactor protein in protecting
10. Perkins SJ, Nealis AS: The quaternary structure in solution of human cells from autologous complement attack. J Immunol 165:3999, 2000.
complement subcomponent C1r2C1s1. Biochem J 263:463, 1989. 29. Morgan B, Harris CL: In Complement regulatory proteins, ed 1, San
11. Rosse WF: Fixation of the first component of complement (C’la) by Diego, CA, 1999, Academic Press, p 382.
human antibodies. J Clin Invest 47:2430, 1969. 30. Ferreira VP, Pangburn MK, Cortes C: Complement control protein
12. Sim RB, Reid KB: C1: Molecular interactions with activating systems. factor H: The good, the bad, and the inadequate. Mol Immunol
Immunol Today 12:307, 1991. 47:2187, 2010.
13. Kang YS, Do Y, Lee HK, et al: A dominant complement fixation 31. Pangburn MK: Cutting edge: Localization of the host recognition func-
pathway for pneumococcal polysaccharides initiated by SIGN-R1 tions of complement factor H at the carboxyl-terminal: Implications for
interacting with C1q. Cell 125:47, 2006. hemolytic uremic syndrome. J Immunol 169:4702, 2002.
13a. Gonzalez SF, Lukacs-Kornek V, Kuligowski MP, et al: Capture of influ- 32. Spitzer D, Mitchell LM, Atkinson JP, et al: Properdin can initiate
enza by medullary dendritic cells via SIGN-R1 is essential for humoral complement activation by binding specific target surfaces and providing
immunity in draining lymph nodes. Nat Immunol 11:427–434, 2010. a platform for de novo convertase assembly. J Immunol 179:2600, 2007.
14. Takahashi M, Iwaki D, Kanno K, et al: Mannose-binding lectin 33. Figueroa JE, Densen P: Infectious diseases associated with complement
(MBL)-associated serine protease (MASP)-1 contributes to activation deficiencies. Clin Microbiol Rev 4:359, 1991.
of the lectin complement pathway. J Immunol 180:6132, 2008. 34. Ratnoff WD, Fearon DT, Austen KF: The role of antibody in the
15. Fraser IP, Koziel H, Ezekowitz RA: The serum mannose-binding activation of the alternative complement pathway. Semin Immunopathol
protein and the macrophage mannose receptor are pattern recognition 6:361, 1983.
molecules that link innate and adaptive immunity. Semin Immunol 35. Fries LF, Gaither TA, Hammer CH, et al: C3b covalently bound to IgG
10:363, 1998. demonstrates a reduced rate of inactivation by factors H and I. J Exp
16. Turner MW: Mannose-binding lectin: The pluripotent molecule of the Med 160:1640, 1984.
innate immune system. Immunol Today 17:532, 1996. 36. Matsumoto I, Macciono M, Lee DM, et al: How antibodies to a
16a. Heja D, Kocsis A, Dobo J, et al: Revised mechanism of comple- ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune
ment lectin-pathway activation revealing the role of serine protease disease. Nat Immunol 4:360, 2002.
MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci USA 37. Volanakis JE: Participation of C3 and its ligands in complement activa-
109:10498–10503, 2012. tion. Curr Top Microbiol Immunol 153:1, 1990.
16b. Degn SE, Jensen L, Hansen AG, et al: Mannan-binding lectin-associ- 38. Rawal N, Pangburn MK: Formation of high affinity C5 convertase of
ated serine protease (MASP)-1 is crucial for lectin pathway activation the classical pathway of complement. J Biol Chem 278:38476, 2003.
in human serum, whereas neither MASP-1 nor MASP-3 is required 39. Bhakdi S, Tranum-Jensen J: Complement lysis: A hole is a hole.
for alternative pathway function. J Immunol 189:3957–3969, 2012. Immunol Today 12:318, Discussion p 321, 1991.
16c. Degn SE, Kjaer TR, Kidmose RT, et al: Complement activation by 40. Esser AF: Big MAC attack: Complement proteins cause leaky patches.
ligand-driven juxtaposition of discrete pattern recognition complexes. Immunol Today 12:316, Discussion p 321, 1991.
Proc Natl Acad Sci USA 111:13445–13450, 2014. 41. Ahearn JM, Fearon DT: Structure and function of the complement
17. Thiel S, Vorup-Jensen T, Stover CM, et al: A second serine protease receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46:183, 1989.
associated with mannan-binding lectin that activates complement. 42. Fischer E, Appay MD, Cook J, et al: Characterization of the human
Nature 386:506, 1997. glomerular C3 receptor as the C3b/C4b complement type one (CR1)
17a. Matsushita M: Ficolins in complement activation. Mol Immunol receptor. J Immunol 136:1373, 1986.
55:22–26, 2013. 43. Walport MJ, Lachmann PJ: Erythrocyte complement receptor type
18. Thompson C: Protein proves to be a key link in innate immunity. 1, immune complexes, and the rheumatic diseases. Arthritis Rheum
Science 269:301, 1995. 31:153, 1988.
19. Shi L, Takahashi K, Dundee J, et al: Mannose-binding lectin-deficient 44. Fearon DT, Ahearn JM: Complement receptor type 1 (C3b/C4b recep-
mice are susceptible to infection with Staphylococcus aureus. J Exp Med tor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus
199:1379, 2004. receptor; CD21). Curr Top Microbiol Immunol 153:83, 1990.
20. Held K, Thiel S, Loos M, et al: Increased susceptibility of complement 45. Helmy KY, Katschke KJ, Jr, Gorgani NN, et al: CRIg: A macrophage
factor B/C2 double knockout mice and mannan-binding lectin knock- complement receptor required for phagocytosis of circulating patho-
out mice to systemic infection with Candida albicans. Mol Immunol gens. Cell 124:915, 2006.
45:3934, 2008. 46. Ember JA, Jagels MA, Hugli TE: Characterization of complement
21. Muller-Eberhard HJ, Schreiber RD: Molecular biology and chemis- anaphylatoxins and their biological responses. In Volanakis JE, Frank
try of the alternative pathway of complement. Adv Immunol 29:1, MM, editors: The human complement system in health and disease, New
1980. York, 1998, Marcel Dekker, p 241.